SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001068238-11-000172
Filing Date
2011-05-11
Accepted
2011-05-11 11:26:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A (AMMENDMENT NO. 2) anthera-13da.htm SC 13D/A 199426
  Complete submission text file 0001068238-11-000172.txt   200917
Mailing Address 1001 BAY HILL DRIVE SUITE 300 SAN BRUNO CA 94066
Business Address 1001 BAY HILL DRIVE SUITE 300 SAN BRUNO CA 94066 6508663100
VANTAGEPOINT VENTURE PARTNERS IV Q LP (Filed by) CIK: 0001129585 (see all company filings)

IRS No.: 943359388 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85368 | Film No.: 11830744
SIC: 2834 Pharmaceutical Preparations